Andexanet Alfa Is Associated With Lower In-Hospital Mortality Compared to 4-Factor Prothrombin Complex Concentrate in Patients With Factor Xa Inhibitor–Related Major Bleeding
Andexanet Alfa Is Associated With Lower In-Hospital Mortality Compared to 4-Factor Prothrombin Complex Concentrate in Patients With Factor Xa Inhibitor–Related Major Bleeding
Emergency Medicine Perspectives: Targeted vs. Nonspecific Approaches to Anticoagulation Reversal in Real World Analyses for ICH or GI Bleeds
Emergency Medicine Perspectives: Targeted vs. Nonspecific Approaches to Anticoagulation Reversal in Real World Analyses for ICH or GI Bleeds
Clinical Implications of ANNEXa-I on the Management of ICH for Neurointensivists and Emergency Physicians
Clinical Implications of ANNEXa-I on the Management of ICH for Neurointensivists and Emergency Physicians
Closing the Gap to Care: Assessing CAD and Improving Patient Outcomes with Revascularization
Closing the Gap to Care: Assessing CAD and Improving Patient Outcomes with Revascularization
Direct from the Heart Failure Clinic: Novel Device Therapy for Patients with HFrEF
Direct from the Heart Failure Clinic: Novel Device Therapy for Patients with HFrEF
Heart Failure Grand Rounds: 3 Things You Need to Know About Cardiac Contractility Modulation
Heart Failure Grand Rounds: 3 Things You Need to Know About Cardiac Contractility Modulation
Experts Discuss Longevity and Durability with TAVR
Experts Discuss Longevity and Durability with TAVR
CARE HK in HF: Designing a Real-world Study to Identify Barriers to Guideline-directed RAASi Therapy
CARE HK in HF: Designing a Real-world Study to Identify Barriers to Guideline-directed RAASi Therapy
